nach oben

Clinical Research in Cardiology

Erschienen in:

16.05.2018 | Review

German contribution to development and innovations in the management of acute myocardial infarction and cardiogenic shock

verfasst von: Hans-Josef Feistritzer, Steffen Desch, Suzanne de Waha, Alexander Jobs, Uwe Zeymer, Holger Thiele

Erschienen in: Clinical Research in Cardiology | Sonderheft 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Treatment of acute coronary syndromes has evolved over time leading to a significantly reduced mortality. Multiple major trials have been performed in Germany leading to new treatment strategies in acute coronary syndromes including cardiogenic shock. This review article will summarize major trials and their impact on guideline recommendations in acute myocardial infarction highlighting reperfusion strategies, antiplatelet regimens, prognosis assessment and also mechanical circulatory support in stable infarction patients and in cardiogenic shock.

de Vreede JJ, Gorgels AP, Verstraaten GM, Vermeer F, Dassen WR, Wellens HJ (1991) Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis. J Am Coll Cardiol 18(3):698–706CrossRefPubMed

Kristensen SD, Laut KG, Fajadet J, Kaifoszova Z, Kala P, Di Mario C et al (2014) Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries. Eur Heart J 35(29):1957–1970CrossRefPubMed

Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R et al (2017) PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med 377(25):2419–2432CrossRefPubMed

Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J et al (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367(14):1287–1296CrossRefPubMed

Thiele H, Ohman EM, Desch S, Eitel I, de Waha S (2015) Management of cardiogenic shock. Eur Heart J 36(20):1223–1230CrossRefPubMed

Niccoli G, Burzotta F, Galiuto L, Crea F (2009) Myocardial no-reflow in humans. J Am Coll Cardiol 54(4):281–292CrossRefPubMed

Zeymer U, Arntz H-R, Mark B, Fichtlscherer S, Werner G, Schöller R et al (2012) Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial. Clin Res Cardiol 101(4):305–312CrossRefPubMed

Montalescot G, van ’t Hof AW, Lapostolle F, Silvain J, Lassen JF, Bolognese L et al (2014) Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med 371(11):1016–1027CrossRefPubMed

Zeymer U, Hohlfeld T, vom Dahl J, Erbel R, Münzel T, Zahn R et al (2017) Prospective, randomised trial of the time dependent antiplatelet effects of 500 mg and 250 mg acetylsalicylic acid i.v. and 300 mg p.o. in ACS (ACUTE). Thromb Haemostasis 117(3):625 – 35CrossRef

10.

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H et al (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119 – 77CrossRefPubMed

11.

Zeymer U, Margenet A, Haude M, Bode C, Lablanche J-M, Heuer H et al (2010) Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI trial. J Am Coll Cardiol 56(6):463–469CrossRefPubMed

12.

Thiele H, Wohrle J, Hambrecht R, Rittger H, Birkemeyer R, Lauer B et al (2012) Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial. Lancet 379(9819):923–931CrossRefPubMed

13.

Eitel I, Wohrle J, Suenkel H, Meissner J, Kerber S, Lauer B et al (2013) Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial. J Am Coll Cardiol 61(13):1447–1454CrossRefPubMed

14.

Kastrati A, Neumann FJ, Schulz S, Massberg S, Byrne RA, Ferenc M et al (2011) Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction. N Engl J Med 365(21):1980–1989CrossRefPubMed

15.

Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O’Keefe J et al (1993) A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 328(10):673–679CrossRefPubMed

16.

Zijlstra F, Hoorntje JC, de Boer MJ, Reiffers S, Miedema K, Ottervanger JP et al (1999) Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 341(19):1413–1419CrossRefPubMed

17.

Schomig A, Kastrati A, Dirschinger J, Mehilli J, Schricke U, Pache J et al (2000) Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. N Engl J Med 343(6):385–391CrossRefPubMed

18.

Kastrati A, Mehilli J, Dirschinger J, Schricke U, Neverve J, Pache J et al (2002) Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial. Lancet 359(9310):920–925CrossRefPubMed

19.

Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP et al (2009) Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med 360(21):2165–2175CrossRefPubMed

20.

Thiele H, Rach J, Klein N, Pfeiffer D, Hartmann A, Hambrecht R et al (2012) Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial). Eur Heart J 33(16):2035–2043CrossRefPubMed

21.

Jobs A, Mehta SR, Montalescot G, Vicaut E, van’t Hof AW, Badings EA et al (2017) Optimal timing of invasive strategy in patients with non-ST-elevation acute coronary syndrome: a collaborative meta-analysis of randomised trials. Lancet 390:737–746CrossRefPubMed

22.

Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F et al (2016) 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 37(3):267–315CrossRefPubMed

23.

Thiele H, de Waha S, Zeymer U, Desch S, Scheller B, Lauer B et al (2014) Effect of aspiration thrombectomy on microvascular obstruction in NSTEMI patients: the TATORT-NSTEMI trial. J Am Coll Cardiol 64(11):1117–1124CrossRefPubMed

24.

Meyer-Saraei R, de Waha S, Eitel I, Desch S, Scheller B, Bohm M et al (2017) Thrombus aspiration in non-ST-elevation myocardial infarction – 12-month clinical outcome of the randomised TATORT-NSTEMI trial. Eur Heart J Acute Cardiovasc Care 6(1):10–17CrossRefPubMed

25.

Jolly SS, James S, Džavík V, Cairns JA, Mahmoud KD, Zijlstra F et al (2017) Thrombus aspiration in ST-segment–elevation myocardial infarction. An individual patient meta-analysis: thrombectomy trialists collaboration. Circulation 135(2):143–152CrossRefPubMed

26.

Cassese S, Kufner S, Xhepa E, Byrne RA, Kreutzer J, Ibrahim T et al (2016) Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials. Clin Res Cardiol 105(7):575–584CrossRefPubMed

27.

Zeymer U, Suryapranata H, Monassier JP, Opolski G, Davies J, Rasmanis G et al (2001) The Na+/H + exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardiol 38:1644–1650CrossRefPubMed

28.

Eitel I, Stiermaier T, Rommel KP, Fuernau G, Sandri M, Mangner N et al (2015) Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial. Eur Heart J 36(44):3049–3057CrossRefPubMed

29.

Katus H, Ziegler A, Ekinci O, Giannitsis E, Stough WG, Achenbach S et al (2017) Early diagnosis of acute coronary syndrome. Eur Heart J 38(41):3049–3055CrossRefPubMed

30.

Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T (1997) Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 337(23):1648–1653CrossRefPubMed

31.

Hamm CW, Heeschen C, Goldmann B, Vahanian A, Adgey J, Miguel CM et al (1999) Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab antiplatelet therapy in unstable refractory angina (CAPTURE) Study Investigators. N Engl J Med 340(21):1623–1629CrossRefPubMed

32.

Keller T, Zeller T, Ojeda F, Tzikas S, Lillpopp L, Sinning C et al (2011) Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 306(24):2684–2693CrossRefPubMed

33.

Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E et al (2009) Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 361(9):868–877CrossRefPubMed

34.

Schroder K, Wegscheider K, Zeymer U, Tebbe U, Schroder R (2001) Extent of ST-segment deviation in a single electrocardiogram lead 90 min after thrombolysis as a predictor of medium-term mortality in acute myocardial infarction. Lancet 358(9292):1479–1486CrossRefPubMed

35.

Schroder R (2004) Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction. Circulation 110(21):e506-10CrossRefPubMed

36.

Eitel I, de Waha S, Wohrle J, Fuernau G, Lurz P, Pauschinger M et al (2014) Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction. J Am Coll Cardiol 64(12):1217–1226CrossRefPubMed

37.

de Waha S, Desch S, Eitel I, Fuernau G, Zachrau J, Leuschner A et al (2010) Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers. Eur Heart J 31:2660–2668CrossRefPubMed

38.

de Waha S, Patel MR, Granger CB, Ohman EM, Maehara A, Eitel I et al (2017) Relationship between microvascular obstruction and adverse events following primary PCI for STEMI: An individual patient data pooled analysis from 7 randomised trials. Eur Heart J 38:3502–3510CrossRefPubMed

39.

Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD et al (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341(9):625 – 34CrossRefPubMed

40.

Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P et al (2006) Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 295(21):2511–2515CrossRefPubMedPubMedCentral

41.

Zeymer U, Vogt A, Zahn R, Weber MA, Tebbe U, Gottwik M et al (2004) Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Eur Heart J 25(4):322–328CrossRefPubMed

42.

Scholz KH, Maier SKG, Maier LS, Lengenfelder B, Jacobshagen C, Jung J et al (2018) Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J 39(13):1065–1074CrossRefPubMedPubMedCentral

43.

Stegman BM, Newby LK, Hochman JS, Ohman EM (2012) Post-myocardial infarction cardiogenic shock is a systemic illness in need of systemic treatment: Is therapeutic hypothermia one possibility? J Am Coll Cardiol 59(7):644–647CrossRefPubMed

44.

Fuernau G, Beck J, Desch S, Eitel I, Erbs S, Mangner N et al. Mild hypothermia in cardiogenic shock complicating myocardial infarction—the randomized SHOCK-COOL pilot trial. Eur Heart J. 2016;Abstract Supplement:P5199

45.

Shah M, Patnaik S, Patel B, Ram P, Garg L, Agarwal M et al (2018) Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States. Clin Res Cardiol 107(4):287–303CrossRefPubMed

46.

Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J et al (2013) Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 382(9905):1638–1645CrossRefPubMed

47.

de Waha S, Graf T, Desch S, Fuernau G, Eitel I, Pöss J et al (2017) Outcome of elderly undergoing extracorporeal life support in refractory cardiogenic shock. Clin Res Cardiol 106(5):379–385CrossRefPubMed

48.

Ouweneel DM, Schotborgh JV, Limpens J, Sjauw KD, Engstrom AE, Lagrand WK et al (2016) Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. Intensive Care Med 42(12):1922–1934CrossRefPubMedPubMedCentral

49.

Thiele H, Jobs A, Ouweneel DM, Henriques JPS, Seyfarth M, Desch S et al (2017) Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials. Eur Heart J 38:3523–3531CrossRefPubMed

Titel: German contribution to development and innovations in the management of acute myocardial infarction and cardiogenic shock
verfasst von: Hans-Josef Feistritzer
Steffen Desch
Suzanne de Waha
Alexander Jobs
Uwe Zeymer
Holger Thiele
Publikationsdatum: 16.05.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Research in Cardiology / Ausgabe Sonderheft 2/2018
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-018-1276-5

Neu im Fachgebiet Kardiologie

23.04.2024 | Ablationstherapie | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

German contribution to development and innovations in the management of acute myocardial infarction and cardiogenic shock

Abstract

Neu im Fachgebiet Kardiologie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Kardiologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 2/2018

Genetics of coronary artery disease in the light of genome-wide association studies

Current developments in cardiac rhythm management devices

From early beginnings to elaborate tools: contribution of German electrophysiology to the interventional treatment of cardiac arrhythmias

Transcatheter aortic valve implantation in Germany

Therapeutic options in advanced heart failure

Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University

Neu im Fachgebiet Kardiologie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Kardiologie